Luglio 06, 202122 Febbraio 2022
9

I progetti H2020-Future and Emerging Technology, VES4US e BOW presenti al workshop EIC-ERC sulla terapia genica e cellulare

Il 29 giugno 2021 il Consiglio europeo dell’innovazione (EIC) e il Consiglio europeo della ricerca (ERC) hanno ospitato il loro primo workshop congiunto sulla terapia genica e cellulare.
https://eic.ec.europa.eu/news/cell-and-gene-therapy-first-eic-erc-workshop-2021-07-02_en
I due progetti europei H2020-FET VES4US e BOW sono stati invitati come esempi di successo delle tendenze scientifiche emergenti; questo workshop è stato di interesse per tutti i partecipanti https://ves4us.eu/ves4us-participates-to-the-eic-erc-workshop-on-gene-and-cell-therapy/;
https://www.bowproject.eu/bow-participates-to-the-eic-erc-workshop-on-gene-and-cell-therapy/

La nostra ricercatrice, Antonella Bongiovanni, coordinatrice di VES4US e partner in BOW è stata relatrice nelle “Sessioni tematiche parallele” su “Nuovi vettori (virali e non) per la terapia genica”.
EIC ed ERC investono e supportano gli studi e l’applicazione delle vescicole extracellulari, straordinarie tecnologie derivate dalle cellule e oggetto dei due progetti europei. Ciò contribuirà allo sviluppo di una nuova piattaforma di rilascio dei farmaci e alla creazione di un nuovo ecosistema europeo per le nanotecnologie di derivazione cellulare.

AGENDA

14:00 – 14:10: Welcome and Introduction

  • Jean-Pierre Bourguignon (President ad interim, ERC Scientific Council)
  • Mark Ferguson (Chair of the EIC Board)

14:10 – 14:50: Keynote speech

  • Luigi Naldini (SR-Tiget, San Raffaele Telethon Institute for Gene Therapy, Italy)

14:50 – 15:10: Plenary session: Current global Cell and Gene Therapy landscape and trends

  • Iordanis Arzimanoglou (Programme Manager EIC)

Break – 10 minutes

15:20 – Thematic parallel sessions

  1. Cell therapy, including stem cell therapy – Moderator: Margaret Buckingham (Institut Pasteur, France)
    • Giulio Cossu (University of Manchester, UK)
    • Michele De Luca (University of Modena and Reggio Emilia, Italy)
    • Carl Figdor (Radboud University, The Netherlands)
    • Magdalena Götz (Ludwig Maximilian University of Munich, Germany) Rogier Reijmers (Lumicks, The Netherlands)
    • Jérémie Laurent (Astraveus, France)
  2. Disease modelling including 3D-bioprinted organs/organoids and other Regenerative Medicine novel approaches – Moderator: Geneviève Almouzni (Institut Curie, France)
    • Hans Clevers (Hubrecht Institute for Developmental Biology and Stem Cell Research, The Netherlands)
    • Prisca Liberali (Friedrich Miescher Institute for Biomedical Research, Switzerland)
    • Christine Mummery (Leiden University, The Netherlands)
    • Matthias Lütolf (EPFL, Switzerland)
    • Øyvind Halaas (Norwegian University Science Technology, Norway)
    • Francesca M. Spagnoli (Centre for Stem Cells and Regenerative Medicine, King’s College London, UK

    03. New vectors (viral and non-viral) for gene therapy – Moderator: Marja Makarow (BioCenter, Finland)

    • Stein Aerts (Flemish Institute for Biotechnology – KU Leuven, Belgium)
    • Zsuzsanna Izsvák (Max Delbrück Centrum for Molecular Medicine, Germany)
    • Federico Mingozzi (Association GENETHON, France & Spark Therapeutics, US)
    • Seppo Ylä-Herttuala (University of Eastern Finland, Finland) Anna Pedrix Rosell (Sixfold Bioscience Ltd, The Imperial College White City Inc Innovation Hub, UK)
    • Antonella Bongiovanni (CNR – Institute of Biomedical Research and Innovation in Palermo, Italy)

04. Novel gene therapy approaches including RNA-based technologies – Moderator: NektariosTavernarakis (Foundation for Research and Technology, Greece)

  • Roman Jerala(National Institute of Chemistry, Slovenia)
  • Thorsten Stafforst(University of Tübingen, Germany)
  • Molly Stevens(Imperial College London, UK)
  • Pieter Vader(University of Utrecht, The Netherlands) Sven Panke (ETH, Switzerland)
  • Stéphane Boissel(Sparingvision, France)Break – 10 minutes

Break – 10 minutes

17:00 – 18:00: Roundtable discussion on transition from research to innovation in Cell and Gene Therapy with – Moderator: Brady Huggett (Senior Editor of Nature Biotechnology)

    • Niccolo Bacchi (Novo Ventures, Denmark)
    • Alessandra Biffi (University of Padua, Italy & Harvard Stem Cell Institute, US)
    • Deniz Kirik (Lund University, Sweden)
    • Jo Bury (Flemish Institute for Biotechnology, Belgium)
    • Erik Gatenholm (Cellink, US, EU)
    • Irene Norstedt (European Commission)

18:00 – 18:05: Conclusions